Dual Marker
- Sample Type
- Serum
- Fasting
- No
- Unit
- MoM
Function
The Dual Marker test (also known as the First Trimester Screening) is a predictive blood test performed between weeks 11 and 14 of pregnancy. It measures two specific analytes: Pregnancy-Associated Plasma Protein-A (PAPP-A) and Free Beta-human Chorionic Gonadotropin (fβ-hCG). The results are converted into a 'Multiple of the Median' (MoM) and combined with maternal age and ultrasound findings (Nuchal Translucency) to calculate a statistical risk score.
Why it is Ordered
This test is ordered to screen for chromosomal abnormalities in the fetus. It is a non-invasive way to assess the likelihood of specific genetic conditions without the immediate risks associated with amniocentesis or chorionic villus sampling (CVS). It provides expectant parents with early information regarding the health of the pregnancy.
Associated Conditions
- Trisomy 21 (Down Syndrome): Typically characterized by low PAPP-A levels and high Free Beta-hCG levels.
- Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome): Generally associated with low levels of both PAPP-A and Free Beta-hCG.
- Placental Insufficiency: Very low PAPP-A levels in the first trimester have been linked to later complications such as preeclampsia or fetal growth restriction.
Panel Components
This test is a profile comprising the following specific markers:
Why Context Matters
A second opinion or confirmatory testing (like NIPT or Amniocentesis) is critical because the Dual Marker is a screening test, not a diagnostic one. It only provides a statistical probability. Confounding factors include inaccurate gestational dating (incorrectly calculating the age of the fetus), maternal weight, smoking status, multiple pregnancies (twins), and whether the pregnancy was conceived via IVF, all of which can skew the analyte concentrations and produce false positives.
Lab ranges are statistical averages, not biological laws. "Normal" for a 20-year-old male isn't normal for a 60-year-old female.
Clinical References
Source-of-truth databases and clinical guidelines for Dual Marker:
Official Sources
- Medical Care of Adults With Down Syndrome: A Clinical Guideline - PubMedpubmed.ncbi.nlm.nih.gov
Research & Guidelines
- PubMed: Dual Marker Clinical GuidelinesNCBI / PubMed
Related Indicators
Medically Reviewed by Dr. Binoy Babu, MBBS
Board Certified Doctor • 10+ Years Clinical Experience
Dr. Babu is a practicing physician dedicated to empowering patients with clear, actionable medical information. He founded 2opi to bridge the gap between complex lab reports and patient understanding, ensuring everyone has access to a reliable second opinion.
Get Notified When Dr. Babu Is Available